Drug Delivery
Total Trials
17
As Lead Sponsor
15
As Collaborator
2
Total Enrollment
2,119
NCT00478179
Study of a Bupivacaine Patch (Eladur™) to Treat Post- Herpetic Neuralgia
Phase: Phase 2
Role: Lead Sponsor
Start: Sep 30, 2006
Completion: Dec 31, 2007
NCT00974350
A Safety and Efficacy Study of SABER®-Bupivacaine for Pain Following Hernia Repair
Start: Jan 31, 2007
Completion: Oct 31, 2007
NCT00485225
Open Label, Safety Study of EN3270 in Patients With Moderate to Severe Non-malignant, Chronic Pain
Start: Jun 30, 2007
Completion: Jul 31, 2008
NCT00818363
A Safety and Effectiveness Study of SABER®-Bupivacaine for Pain Following Shoulder Surgery
Start: Dec 31, 2008
Completion: Oct 31, 2009
NCT00993798
An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Following Arthroscopic Shoulder Surgery
Start: Apr 30, 2009
Completion: Nov 30, 2011
NCT00993226
An International Trial to Evaluate the Efficacy and Safety of SABER®-Bupivacaine for Postoperative Pain Control in Patients Undergoing Hysterectomy
Start: May 31, 2009
Completion: Jul 31, 2010
NCT01052012
Bupivacaine Effectiveness and Safety in SABER® Trial
Phase: Phase 3
Start: Dec 31, 2009
Completion: Sep 30, 2011
NCT01096966
Study of the Efficacy and Safety of Bupivacaine TTS Patch in Patients With Chronic Low Back Pain
Start: Mar 31, 2010
Completion: Feb 28, 2011
NCT01139866
An Extension Trial to Evaluate Long-term Safety of SABER™-Bupivacaine for Pain Following Shoulder Surgery
Phase: N/A
Start: Jun 30, 2010
Completion: Apr 30, 2011
NCT02450890
Evaluate Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
Role: Collaborator
Start: Jun 30, 2015
Completion: Feb 28, 2017
NCT02574520
Trial of Extended Release Bupivacaine for Pain Relief After Surgery
Start: Nov 30, 2015
Completion: Aug 31, 2017
NCT02704390
Evaluate Long-term Safety and Efficacy of ORADUR®-Methylphenidate in Children and Adolescents With ADHD
Start: Jan 31, 2016
Completion: Aug 31, 2019
NCT03394781
A Research Study to Evaluate Safety and Efficacy of DUR-928 in Subjects With Primary Sclerosing Cholangitis (PSC)
Start: Jan 22, 2018
Completion: Jan 31, 2019
NCT03432260
A Research Study to Assess the Safety, Pharmacokinetics and Pharmacodynamics of DUR-928 in Patients With Alcoholic Hepatitis
Start: Apr 18, 2018
Completion: Sep 9, 2019
NCT03837743
Safety and Efficacy Study of DUR-928 Topical Solution in Subjects With Plaque Psoriasis
Start: Feb 21, 2019
Completion: May 20, 2020
NCT04447404
DUR-928 in Subjects With SARS-CoV-2 With Acute Lung, Liver or Kidney Injury
Start: Sep 21, 2020
Completion: Mar 4, 2021
NCT04563026
A Phase 2b Study in Subjects With Alcoholic Hepatitis to Evaluate Safety and Efficacy of DUR-928 Treatment
Start: Jan 22, 2021
Completion: Sep 6, 2023
Loading map...